Precision Optics Corporation AI Stock Analysis
Want to see POCI full AI Analyst Report?
Precision Optics Corporation (POCI) AI Stock Analysis
Precision Optics Corporation
(NASDAQ:POCI)
The overall score of 46 reflects a high-risk, early-stage company with significant near-term headwinds. The most significant factors are the weak financial performance, characterized by negative cash flow and unprofitability, and the bearish technical trend with the stock trading below all major moving averages. These are partially offset by a moderately positive earnings call outlook, where management detailed a credible recovery plan with multiple programs transitioning to production and reiterated annual guidance. The company's low-debt balance sheet provides a runway, but until revenue growth translates into positive earnings and cash flow, the stock remains under pressure.
Precision Optics Corporation Key Performance Indicators (KPIs)
Revenue by SegmentBreaks down revenue by different business segments, highlighting which parts of the company are driving growth and profitability, and where there might be challenges or opportunities for expansion.
Precision Optics Corporation's Engineering Design Services segment experienced a significant revenue decline after a peak in early 2024, indicating potential challenges in maintaining client demand or project completions. Conversely, Optical Components show resilience with consistent growth, suggesting strong market demand or successful product innovations. The Medical Device Products & Assemblies segment is facing a downturn, possibly due to competitive pressures or market saturation. The absence of revenue from Systems Manufacturing and Technology Rights highlights a focus on core segments. Investors should watch for strategic pivots or new initiatives to drive growth.
Precision Optics Corporation (POCI) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $44.75M
- Dividend Yield
- ―
- Average Volume (3M)
- 44.02K
- Price to Earnings (P/E)
- -13.7
- Beta (1Y)
- 0.32
- Revenue Growth
- 52.97%
- EPS Growth
- 65.02%
- Country
- US
- Employees
- 108
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Instruments & Supplies
Precision Optics Corporation Business Overview & Revenue Model
Company Description
Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the Euro...
Precision Optics Corporation Earnings Call Summary
The call was broadly optimistic despite a near-term revenue and profitability dip caused by the established satellite customer’s demand pullback and the delayed production start for the second satellite program. Year-over-year revenue, gross margin, operating loss, net loss, and adjusted EBITDA all improved, while multiple medical, defense, aerospace, and satellite programs are progressing toward production. Management reiterated fiscal 2027 guidance and expects recovery in the second half, although Q2 is expected to be the weakest quarter and several market opportunities remain in development.
Q1-2027 Updates
Positive Updates
Negative Updates
Company Guidance
Management reiterated fiscal 2027 guidance for revenue of $30 million to $33 million and an adjusted EBITDA loss of $1.2 million to $1.7 million, expects the second quarter to be the weakest of the year with a substantial adjusted EBITDA loss larger than the loss in the first quarter, and expects satellite subassembly revenue of $1.2 million in Q2 and approximately $2 million for each of Q3 and Q4, with revenue on this program expected to recover in Q3 and Q4. The four programs transferring to production are expected to reach a combined annual run rate of $1.5 million to $2 million per year by the end of this fiscal year and eventually contribute approximately $5 million to $6 million annually; the micro arthroscope is expected to start at about $100,000 a quarter and could double or even triple from that level, while the ophthalmic program could double in the next couple of quarters. Ross revenue is anticipated to continue at $1.3 million for the remainder of fiscal 2027, quarterly revenue is expected to again reach new record highs beyond Q2, and the second satellite customer now anticipates production to begin about a year from now in the fourth quarter of calendar 2028.
Precision Optics Corporation Financial Statement Overview
Summary
Financial performance is weak. While TTM revenue growth is strong, profitability is a major concern with contracting gross margins (19% TTM) and persistent net losses. Cash flow is negative, with the company burning cash to fund operations. The balance sheet is stable with low debt, providing a cushion, but the inability to convert growth into positive earnings and cash generation is a significant risk.
Income Statement
28NegativeBalance Sheet
55NeutralCash Flow
35Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Sep 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.00M | 31.53M | 19.09M | 19.10M | 21.04M | 15.68M |
| Gross Profit | 6.32M | 5.43M | 3.40M | 5.80M | 7.73M | 4.93M |
| EBITDA | -2.08M | -3.20M | -5.34M | -2.51M | 286.99K | -581.59K |
| Net Income | -2.47M | -3.63M | -5.78M | -2.95M | -144.61K | -928.42K |
Balance Sheet | ||||||
| Total Assets | 30.62M | 32.34M | 19.79M | 16.91M | 19.74M | 16.70M |
| Cash, Cash Equivalents and Short-Term Investments | 8.97M | 9.84M | 1.77M | 405.28K | 2.93M | 605.75K |
| Total Debt | 3.83M | 4.06M | 2.04M | 3.43M | 3.16M | 3.00M |
| Total Liabilities | 10.42M | 11.99M | 7.53M | 6.84M | 7.69M | 7.73M |
| Stockholders Equity | 20.20M | 20.35M | 12.26M | 10.07M | 12.05M | 8.97M |
Cash Flow | ||||||
| Free Cash Flow | -2.51M | -1.98M | -3.77M | -2.98M | -133.59K | -1.09M |
| Operating Cash Flow | -2.30M | -1.55M | -3.55M | -2.68M | -81.09K | -933.37K |
| Investing Cash Flow | -175.59K | -429.35K | -233.47K | -293.88K | -52.50K | -407.80K |
| Financing Cash Flow | 10.05M | 10.05M | 5.15M | 456.32K | 2.45M | 1.09M |
Precision Optics Corporation Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For POCI, the sentiment is Negative. The current price of 4.07 is below the 20-day moving average (MA) of 4.68, below the 50-day MA of 4.53, and below the 200-day MA of 4.61, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 35.49 is Neutral, neither overbought nor oversold. The STOCH value of 3.48 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for POCI.
Precision Optics Corporation Risk Analysis
Precision Optics Corporation disclosed 32 risk factors in its most recent earnings report. Precision Optics Corporation reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
2 New RisksPrecision Optics Corporation Peers Comparison
Overall Rating
POCI46Neutral
RVP43Neutral
MLSS42Neutral
NXGL33Underperform
FEMY28Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 46Neutral | $44.75M | -13.72 | -14.10% | ― | 52.97% | 65.02% | |
| 43Neutral | $17.93M | -2.85 | -8.48% | ― | 0.12% | 5.16% | |
| 42Neutral | $21.93M | -5.80 | -122.29% | ― | 3.93% | 48.18% | |
| 33Underperform | $10.46M | -0.22 | -151.60% | ― | 5.54% | -98.10% | |
| 28Underperform | $10.91M | -0.32 | -114.48% | ― | -4.21% | 78.58% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| POCI | Precision Optics Corporation, Inc. | 4.07 | -0.53 | -11.52% | |
| RVP | Retractable Technologies | 0.60 | -0.22 | -26.95% | |
| MLSS | Milestone Scientific Inc | 0.24 | -0.07 | -21.94% | |
| FEMY | Femasys, Inc. | 1.26 | -17.12 | -93.15% | |
| NXGL | Nexgel, Inc. | 3.35 | -28.25 | -89.40% |
Precision Optics Corporation Corporate Events
Precision Optics Signs New Facility Lease Agreement
PositiveOn October 28, 2026, Precision Optics Corporation, Inc. entered into a new lease agreement with Equity Assets, Inc. for its existing facility at 22-28 East Broadway in Gardner, Massachusetts, covering approximately 12,292 rentable square feet of comm...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 20, 2026
